Today: September 11, 2024
Today: September 11, 2024

Dementia

Uncategorized

Nurses report alarming violence in dementia care facilities

An investigation into dementia care facilities across the United States has revealed a concerning trend of resident-on-resident violence, raising questions about the safety of vulnerable individuals and the challenges faced by caregivers.

Nurses report alarming violence in dementia care facilities
Health

LGBTQ+ caregivers of people with dementia face unique stresses that lead to poorer physical and mental health

Discrimination, isolation and stigma related to sexual orientation or gender identity likely contribute to the higher rates of depression and lower quality of life of LGBTQ+ caregivers.

LGBTQ+ caregivers of people with dementia face unique stresses that lead to poorer physical and mental health
Business|Health|News|World

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen

Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
Business|Health

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

The first drug shown to slow Alzheimer’s hit the U.S. market over a year ago, but sales have lagged and diagnosis and treatment remain complicated

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
Health

Hospice care for those with dementia falls far short of meeting people’s needs at the end of life

When dementia patients on Medicare enroll in hospice, they lose other crucial supports and services.

Hospice care for those with dementia falls far short of meeting people’s needs at the end of life
Health|Science

Japan's Eisai developing dementia drug for US market, Nikkei reports

Japanese drugmaker Eisai is developing a dementia treatment that it aims to commercialise in the U.S. by fiscal 2030, the Nikkei reported on Sunday.

Japan's Eisai developing dementia drug for US market, Nikkei reports
Health|Science

A simple tool may be able to predict your risk for both dementia and depression, study finds

A simple tool may be able to predict your risk for both dementia and depression, study finds

A simple tool may be able to predict your risk for both dementia and depression, study finds

Follow